Article: Anthrax Vaccine Award Rescheduled to Nov. 5; VaxGen Believes It Is the Only Firm Negotiating for Award; Company Provides Update on Financial Statements.

Article: VaxGen Provides Update Regarding Financial ...
PR Newswire;  November 1, 2005 ;     700+ words ... ... of its own restated financial statements and filings for 2001 ... annual and quarterly financial statements and filings for 2004 ... toward filing its own financial statements." Next-Generation Anthrax Vaccine Program VaxGen also ...

Article: Anthrax vaccine award rescheduled.
Anti-Infectives Week;  November 15, 2004 ;     700+ words ... ... skin). VaxGen's anthrax vaccine candidate, rPA102 ... of a stockpile of anthrax vaccine for civilian use ... requires an rPA anthrax vaccine. VaxGen also announced ... file its restated financial statements with the U.S ...

Article: San Jose, Calif., area firm to produce anthrax ...
Knight Ridder/Tribune Business News;  November 5, 2004 ;     700+ words ... ... produce 75 million doses of a new anthrax vaccine, which will be stored in a ... its inability to file timely financial statements. "It's really a sea change ... contracts. The earlier, classic anthrax vaccine, from BioPort in Michigan ...

Article: VAXGEN WINS $878M BIOSHIELD CONTRACT FOR ANTHRAX ...
BIOWORLD Today;  November 8, 2004 ;     700+ words ... ... million contract to supply anthrax vaccine for civilian defense ... recombinant Protective Antigen anthrax vaccine (rPA102) to the Strategic ... January, upon the filing of financial statements that incorporate a new ... doses. The only approved anthrax vaccine in the U.S. ...

Article: Use of anthrax vaccine in response to terrorism: ...
Morbidity and Mortality Weekly Report;  November 15, 2002 ;     700+ words ... ... recommendations for using anthrax vaccine in the United States (1 ... concerns that the current anthrax vaccine supply is limited, ACIP ... recommendations on using anthrax vaccine in response to terrorism ...

Article: Efficacy of US Anthrax Vaccine Questioned.
Korea Times (Seoul, Korea);  January 5, 2000 ;     700+ words ... ... say. However, in the case of an anthrax vaccine, manufactured in the U.S. and ... at one year intervals. Under the anthrax vaccine implementation program (AVIP) for ... about the potency or efficacy of the anthrax vaccine manufactured by Michigan Biologic ...

Article: VaxGen Awarded $80.3 Million NIAID Contract for Advanced ...
PR Newswire;  October 1, 2003 ;     700+ words ... ... for the advanced development of its anthrax vaccine candidate, rPA102. The 3-year ... contract for a national stockpile of anthrax vaccine. (Logo: http://www.newscom ... recombinant Protective Antigen (rPA) anthrax vaccine, pending legislation known as Project ...